Business News • PR NewsWire • Cell Therapeutics Reports New Data Demonstrating That Complete Responses to Pixuvri Are Correlated With Prolonged Survival in Patients With Relapsed or Refractory Aggressive NHL

Cell Therapeutics Reports New Data Demonstrating That Complete Responses to Pixuvri Are Correlated With Prolonged Survival in Patients With Relapsed or Refractory Aggressive NHL

Cell Therapeutics Reports New Data Demonstrating That Complete Responses to Pixuvri Are Correlated With Prolonged Survival in Patients With Relapsed or Refractory Aggressive NHL

SEATTLE, June 11 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (the "Company") (Nasdaq and MTA: CTIC) today reported exploratory analyses of the data at study completion from the Company's pivotal PIX301 trial of Pixuvri(TM) (pixantrone dimaleate), the first randomized controlled trial in patien

View More : http://www.prnewswire.com/news-releases/cell-therapeutics-reports-new-data-demonstrating-that-complete-responses-to-pixu...

Releted News by prnewswire

Helix BioPharma Corp. Announces Fiscal Q3 2010 Results

Fraport Traffic Figures - May 2010: Impressive Growth in Passenger and Airfreight Traffic at Frankfurt